肝硬化%心室功能,左%评价研究
肝硬化%心室功能,左%評價研究
간경화%심실공능,좌%평개연구
Liver cirrhosis%Ventricular function,left%Evaluation studies
目的 评价终末期肝病患者终末期肝病模型(MELD)评分与左心功能的关系.方法 回顾性分析2002年1月-2008年5月进行原位肝移植的患者92例的术前临床资料.其中男性75例,女性17例,年龄(50.3±9.5)岁;85例为肝硬化,7例同时伴有原发性肝癌.分析资料包括血液生物化学指标、凝血指标,肝炎病毒学标志物和二维心脏超声、心电图等.根据MELD评分系统将其分为3组:MELD评分≤9分31例;10分≤MELD评分≤19分45例; MELD评分≥20分16例.采用x2检验、方差分析,秩和检验和相关分析等方法判断MELD评分与心功能之间的关系.结果 MELD评分与左房内径(LAD)、室间隔厚度(IVST)、左室舒张末期内径(LVEDD)、主动脉瓣流速(AF)、心输出量(CO)、QRS间期(QRSI)、校正的QT间期(QTc)等呈正相关,r分别为0.317,0.341,0.228,0.387,0.325,0.209和0.347;P值均<0.01;除QRSI外,上述指标及左室后壁厚度亦与国际标准化比率呈正相关,r分别为0.282,0.319,0.322,0.435,0.275,0.320和0.237;P<0.05或P<0.01; LAD、LVEDD、AF,CO、QTc与血清总胆红素呈正相关,r值分别为0.241,0.219,0.357,0.246和0.253;P值均<0.05;IVST和二尖瓣流速E/A与血清肌酐相关,r值分别为0.216和-0.343;P<0.05或P<0.01.E/A≤1在研究对象中的比例为46.7%(43/92),在MELD分级的3组中比例分别为48.4%(15/31),35.6%(16/45)和75.0%(12/16),其中,MELD 10~19分组和MELD评分≥20分组间,x2=7.359,P=0.009,差异有统计学意义.结论 随着终末期肝病的进展,心脏的结构,功能及电生理活动逐渐减退.
目的 評價終末期肝病患者終末期肝病模型(MELD)評分與左心功能的關繫.方法 迴顧性分析2002年1月-2008年5月進行原位肝移植的患者92例的術前臨床資料.其中男性75例,女性17例,年齡(50.3±9.5)歲;85例為肝硬化,7例同時伴有原髮性肝癌.分析資料包括血液生物化學指標、凝血指標,肝炎病毒學標誌物和二維心髒超聲、心電圖等.根據MELD評分繫統將其分為3組:MELD評分≤9分31例;10分≤MELD評分≤19分45例; MELD評分≥20分16例.採用x2檢驗、方差分析,秩和檢驗和相關分析等方法判斷MELD評分與心功能之間的關繫.結果 MELD評分與左房內徑(LAD)、室間隔厚度(IVST)、左室舒張末期內徑(LVEDD)、主動脈瓣流速(AF)、心輸齣量(CO)、QRS間期(QRSI)、校正的QT間期(QTc)等呈正相關,r分彆為0.317,0.341,0.228,0.387,0.325,0.209和0.347;P值均<0.01;除QRSI外,上述指標及左室後壁厚度亦與國際標準化比率呈正相關,r分彆為0.282,0.319,0.322,0.435,0.275,0.320和0.237;P<0.05或P<0.01; LAD、LVEDD、AF,CO、QTc與血清總膽紅素呈正相關,r值分彆為0.241,0.219,0.357,0.246和0.253;P值均<0.05;IVST和二尖瓣流速E/A與血清肌酐相關,r值分彆為0.216和-0.343;P<0.05或P<0.01.E/A≤1在研究對象中的比例為46.7%(43/92),在MELD分級的3組中比例分彆為48.4%(15/31),35.6%(16/45)和75.0%(12/16),其中,MELD 10~19分組和MELD評分≥20分組間,x2=7.359,P=0.009,差異有統計學意義.結論 隨著終末期肝病的進展,心髒的結構,功能及電生理活動逐漸減退.
목적 평개종말기간병환자종말기간병모형(MELD)평분여좌심공능적관계.방법 회고성분석2002년1월-2008년5월진행원위간이식적환자92례적술전림상자료.기중남성75례,녀성17례,년령(50.3±9.5)세;85례위간경화,7례동시반유원발성간암.분석자료포괄혈액생물화학지표、응혈지표,간염병독학표지물화이유심장초성、심전도등.근거MELD평분계통장기분위3조:MELD평분≤9분31례;10분≤MELD평분≤19분45례; MELD평분≥20분16례.채용x2검험、방차분석,질화검험화상관분석등방법판단MELD평분여심공능지간적관계.결과 MELD평분여좌방내경(LAD)、실간격후도(IVST)、좌실서장말기내경(LVEDD)、주동맥판류속(AF)、심수출량(CO)、QRS간기(QRSI)、교정적QT간기(QTc)등정정상관,r분별위0.317,0.341,0.228,0.387,0.325,0.209화0.347;P치균<0.01;제QRSI외,상술지표급좌실후벽후도역여국제표준화비솔정정상관,r분별위0.282,0.319,0.322,0.435,0.275,0.320화0.237;P<0.05혹P<0.01; LAD、LVEDD、AF,CO、QTc여혈청총담홍소정정상관,r치분별위0.241,0.219,0.357,0.246화0.253;P치균<0.05;IVST화이첨판류속E/A여혈청기항상관,r치분별위0.216화-0.343;P<0.05혹P<0.01.E/A≤1재연구대상중적비례위46.7%(43/92),재MELD분급적3조중비례분별위48.4%(15/31),35.6%(16/45)화75.0%(12/16),기중,MELD 10~19분조화MELD평분≥20분조간,x2=7.359,P=0.009,차이유통계학의의.결론 수착종말기간병적진전,심장적결구,공능급전생리활동축점감퇴.
Objective To evaluate the correlations between MELD score and left ventricular function in patients with end-stage liver disease. Methods Atotal of 92 patients who prepared for orthotopic liver transplantation from January 2002 to May 2008 were enrolled in this study. Of these Patients, 75 were males and 17 were females, and the mean age was 50.3 ± 9.5 years; 85 were cirrhosis, 7 were cirrhosis with primary liver cancer. Preoperative information, including biochemical parameters, coagulation parameters, indicators of hepatitis virology, two-dimensional echocardiography and electrocardiogram were collected. According to MELD (the Model for End-stage Liver Disease) scoring system, these subjects were categorized into three groups: MELD score ≤ 9 points (31 cases, 33.7%); 10 ≤ MELD score ≤ 19 points (45 cases, 48.9%);MELD score ≥ 20 points (16 cases, 17.4%). The relationships between MELD score and classification and cardiac function were determined by chi-square test, analysis of variance, rank sum test and correlation analysis,et al. Results MELD score was significantly correlated with left atrial diameter (LAD), interventricular septum thickness (IVST), left ventricular end-diastolic diameter (LVEDD), aortic flow (AF), cardiac output (CO), QRS interval (QRSI) and corrected QT interval (QTc) (r = 0.317, 0.341, 0.228, 0.387, 0.325, 0.209 and 0.347, respectively; P < 0.01, respectively); except QRSI, these variables and left ventricular posterior wall thickness (LVPWT) were also correlated with INR (a MELD component) (r = 0.282, 0.319, 0.322, 0.435,0.275, 0.320 and 0.237, respectively; P < 0.01, respectively); LAD, LVEDD, AF, CO and QTc were correlated with serum total bilirubin (r = 0.241, 0.219, 0.357, 0.246 and 0.253, respectively; P < 0.05, respectively);IVST and E/A ratio (A blood flow [from left atrium to left ventricular] velocity ratio between early diastole [E wave] and late diastole[A wave] ) were correlated with serum creatinine (r = 0.216 and -0.343; P < 0.05 and 0.01); the proportion of E/A ≤ 1 in all subjects was 46.7% (43/92), and 48.4% (15/31), 35.6% (16/45) and 75.0% (12/16) in each group, besides, there was statistically significant difference between 10 ≤ MELD score ≤ 19 points group and MELD score ≥ 20 points group ( x 2 = 7.359, P = 0.009). Conclusions There are different degrees of left ventricular structure, function and electrophysiological changes in patients with end-stage liver disease, these anomalies also will be increased with the MELD score increasing.